2004 (15 POSTS)
Grasty RC , Roberts N, Grey BE, Lau C, Rogers JM. 2004. Perfluorooctane sulfonate (PFOS) alters lung development in the neonatal rat. Birth Defects Res A 70(5):42.
Topics: PFAS
2003 (9 POSTS)
Haws L . Combustion risk modeling and assessment. Presented at the Texas Commission on Environmental Quality Workshop on Hazardous Waste Combustion, Austin, TX, May 2003.
Topics: modeling , risk assessment
Perry CS . Process for development of protective concentration levels for remediation sites in Texas. Presented at Society for Environmental Toxicology and Chemistry (SETAC) meeting, Austin, TX, November 2003.
Topics: remediation
Staskal DF , DeVito MJ, Ross DG, Birnbaum LS. A comparison of the metabolism of methoxyresorufin, acetanilide, and caffeine in rat and human CYP1A2 SUPERSOMES, Society of Toxicology 42nd Annual Meeting, Salt Lake City, UT, 2003.
Topics: Toxicology
Staskal DF , DeVito MJ, Ross DG, Birnbaum LS. Caffeine, acetanilide, and methoxyresorufin metabolism by rat and human CYP1A2 SUPERSOMES and their inhibition by 2,3,7,8,-tetrachlorodibenzo-p-dioxin (TCDD). Dioxin 2003, Boston, MA, 2003. Organohalogen Compounds 64:324-327 .
View Abstract
Topics: dioxin
Grasty RC , Grey BE, Lau CS, Rogers JM. 2003. Window of susceptibility to perfluorooctane sulfonate (PFOS)-induced neonatal mortality in the rat. Birth Defects Research B 68(3):5.
Topics: PFAS
Panko JM . Mold problems in buildings. Solving water intrusion and mold problems in Pennsylvania. Lorman Education Services, Altoona, PA, November 5, 2003.
Topics: Environmental Science
Panko JM . AWMA/Healthy indoor partnerships. International Conference on Indoor Air Quality/Health Indoor Environment, Mold Contamination Case Studies, 2003.
Topics: Environmental Science
Panko JM , Shay EC, Unice KM. Risk perception: The reoccupancy of Lower Manhattan office space following the national tragedies of September 11, 2001. Poster at the Society for Risk Analysis Annual Conference, December 2003.
Topics: risk analysis
Clewell H, Crump K, Covington T , Gentry R, Yeager J. A risk assessment for inhaled arsenic based on urinary arsenic concentration using a pharmacokinetic model. Poster presented at the Society of Toxicology Annual Meeting, Salt Lake City, UT, March 2003.
Topics: arsenic , pharmacokinetics
2002 (7 POSTS)
Haws L . Permitting of hazardous waste combustion facilities in the state of Texas: Human health risks associated with fugitive emissions sources. Presented at the Texas Chemical Council Quarterly Meeting. Houston, TX, August 2002.
Topics: risk assessment
Haws L . Texas risk reduction program rule-The basics. Question and Answer Forum Panelist. Presented at the Texas Natural Resource Conservation Commission Environmental Trade Fair. Waste Remediation Track, Austin, TX, May 2002.
Topics: risk assessment
Haws L . Toxicology and risk assessment resources and practices in the state of Texas. Presented at the USEPA Region 6 States Risk Assessment Roundtable, Dallas, TX, April 2002.
Topics: risk assessment
Perry CS . TRRP Rule – The basics part 2: Human health PCLs and look-up tables. TNRCC Environmental Trade Fair presentation and paper, 2002.
Topics: Exposure Assessment , risk assessment
Grasty RC , Grey BE, Thibodeaux J, Lau C, Rogers JM . Critical period for increased neonatal mortality induced by perfluorooctane sulfonate (PFOS) in the rat. Society of Toxicology 41st Annual Meeting, Nashville, TN, March 2002.
Topics: PFAS
Staskal DF , DeVito MJ, Ross DG, Birnbaum LS. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Society of Toxicology 41st Annual Meeting, Nashville, TN, March 2002.
Topics: dioxin
Gentry R, Teeguarden J, Sarangapani R, Covington T , Lawrence G, McDonald T, Shipp A, Clewell H. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences in tissue dosimetry. Poster presented at Society of Toxicology 41st Annual Meeting, Nashville, TN, March 2002.
Topics: pharmacokinetics
2001 (4 POSTS)
Covington TR , Teeguarden J, Sarangapani R, Gentry PR, Clewell HJ. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Presentation at the Annual Society for Risk Analysis Conference, Seattle, WA, December 2001.
Topics: pharmacokinetics
Haws, L . Risk assessment coordination between EPA and states panelist. Presented at the USEPA Regional Risk Assessors Annual Conference. Bandera, TX, May 2001.
Topics: risk assessment
Haws L . Texas risk reduction program rule-Practical applications. Question and Answer Forum Panelist. Presented at the Texas Natural Resource Conservation Commission Environmental Trade Fair, Waste Remediation Track, Austin, TX, April 2001.